» Articles » PMID: 9971823

Interaction Between the Negative Regulator of Splicing Element and a 3' Splice Site: Requirement for U1 Small Nuclear Ribonucleoprotein and the 3' Splice Site Branch Point/pyrimidine Tract

Overview
Journal J Virol
Date 1999 Feb 11
PMID 9971823
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The negative regulator of splicing (NRS) from Rous sarcoma virus suppresses viral RNA splicing and is one of several cis elements that account for the accumulation of large amounts of unspliced RNA for use as gag-pol mRNA and progeny virion genomic RNA. The NRS can also inhibit splicing of heterologous introns in vivo and in vitro. Previous data showed that the splicing factors SF2/ASF and U1, U2, and U11 small nuclear ribonucleoproteins (snRNPs) bind the NRS, and a correlation was established between SF2/ASF and U11 binding and activity, suggesting that these factors are important for function. These observations, and the finding that a large spliceosome-like complex (NRS-C) assembles on NRS RNA in nuclear extract, led to the proposal that the NRS is recognized as a minor-class 5' splice site. One model to explain NRS splicing inhibition holds that the NRS interacts nonproductively with and sequesters U2-dependent 3' splice sites. In this study, we provide evidence that the NRS interacts with an adenovirus 3' splice site. The interaction was dependent on the integrity of the branch point and pyrimidine tract of the 3' splice site, and it was sensitive to a mutation that was previously shown to abolish U11 snRNP binding and NRS function. However, further mutational analyses of NRS sequences have identified a U1 binding site that overlaps the U11 site, and the interaction with the 3' splice site correlated with U1, not U11, binding. These results show that the NRS can interact with a 3' splice site and suggest that U1 is of primary importance for NRS splicing inhibition.

Citing Articles

At the Intersection of Major and Minor Spliceosomes: Crosstalk Mechanisms and Their Impact on Gene Expression.

Akinyi M, Frilander M Front Genet. 2021; 12:700744.

PMID: 34354740 PMC: 8329584. DOI: 10.3389/fgene.2021.700744.


RNA processing control in avian retroviruses.

McNally M Front Biosci. 2008; 13:3869-83.

PMID: 18508481 PMC: 2575692. DOI: 10.2741/2975.


Characterization of Rous sarcoma virus polyadenylation site use in vitro.

Maciolek N, McNally M Virology. 2008; 374(2):468-76.

PMID: 18272196 PMC: 2413101. DOI: 10.1016/j.virol.2008.01.012.


Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.

Maciolek N, McNally M J Virol. 2007; 81(20):11208-17.

PMID: 17670832 PMC: 2045511. DOI: 10.1128/JVI.00919-07.


New way of regulating alternative splicing in retroviruses: the promoter makes a difference.

Bohne J, Schambach A, Zychlinski D J Virol. 2007; 81(7):3652-6.

PMID: 17229710 PMC: 1866029. DOI: 10.1128/JVI.02105-06.


References
1.
Zhang M, Zamore P, Carmo-Fonseca M, Lamond A, Green M . Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit. Proc Natl Acad Sci U S A. 1992; 89(18):8769-73. PMC: 50002. DOI: 10.1073/pnas.89.18.8769. View

2.
Bennett M, Michaud S, Kingston J, REED R . Protein components specifically associated with prespliceosome and spliceosome complexes. Genes Dev. 1992; 6(10):1986-2000. DOI: 10.1101/gad.6.10.1986. View

3.
Zamore P, Patton J, Green M . Cloning and domain structure of the mammalian splicing factor U2AF. Nature. 1992; 355(6361):609-14. DOI: 10.1038/355609a0. View

4.
McNally M, Gontarek R, Beemon K . Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology. 1991; 185(1):99-108. DOI: 10.1016/0042-6822(91)90758-4. View

5.
Michaud S, REED R . An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev. 1991; 5(12B):2534-46. DOI: 10.1101/gad.5.12b.2534. View